India  
 
NewsR.in

Why some FDA advisers voiced reluctance during vaccine vote

Video Credit: ABC 10 News | San Diego - Duration: 03:32s - Published
Why some FDA advisers voiced reluctance during vaccine vote

Why some FDA advisers voiced reluctance during vaccine vote

Some members of the FDA’s advisory panel expressed a note of reluctance during Tuesday’s vote on the Pfizer vaccine for children aged 5 to 11.


You Might Like


Related videos from verified sources

FDA Authorizes Pfizer’s COVID-19 Vaccine for Kids Ages 5 to 11 [Video]

FDA Authorizes Pfizer’s COVID-19 Vaccine for Kids Ages 5 to 11

FDA Authorizes , Pfizer’s COVID-19 Vaccine, for Kids Ages 5 to 11. On October 29, the Food and Drug Administration gave authorization for Pfizer-BioNTech's COVID-19 vaccine for children ages 5 to..

Credit: Wibbitz Top Stories     Duration: 01:30Published
FDA approves Pfizer vaccine for children [Video]

FDA approves Pfizer vaccine for children

The Food and Drug Administration's vaccine advisers are recommending Pfizer's COVID-19 vaccine for five-to-eleven-year-olds. Tuesday's vote was 17-to-0, with one member not voting.

Credit: 23ABC News | Bakersfield     Duration: 00:43Published